Mitapivat

Mitapivat is a novel, first-in-class pyruvate kinase activator. It works to increase the activity of erythrocyte pyruvate kinase, a key enzyme involved in the survival of red blood cells. It is grouped under the following drug class(es): Sickle cell agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include mitapivatum and PK-R Activator AG-348. Its PubChem CID is 59634741.

CAS No 1260075-17-9
Molecular Formula C24H26N4O3S
Molecular Weight 450.60 g/mol
Synonyms N-[4-[4-(cyclopropylmethyl)piperazine-1-carbonyl]phenyl]quinoline-8-sulfonamide

Frequently Asked Questions